Skip to Content
Morningstar

Fidelity Advisor Biotechnology C FBTCX

Morningstar Medalist Rating
Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 21.91  /  −1.08 %
  • Total Assets 1.8 Bil
  • Adj. Expense Ratio
    1.760%
  • Expense Ratio 1.760%
  • Distribution Fee Level Low
  • Share Class Type Level Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment —
  • Status Open
  • TTM Yield —
  • Turnover 78%

USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:10 PM GMT+0

Morningstar’s Analysis FBTCX

Will FBTCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable FBTCX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the FBTCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of FBTCX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Strength in Fidelity Advisor Biotechnology C's People Pillar is partially offset by an Average Process Pillar rating, leading to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FBTCX

More FBTCX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 62.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AbbVie Inc

24.05 427.7 Mil
Healthcare

Amgen Inc

9.25 164.6 Mil
Healthcare

Regeneron Pharmaceuticals Inc

7.98 141.8 Mil
Healthcare

Ascendis Pharma A/S ADR

3.95 70.2 Mil
Healthcare

Alnylam Pharmaceuticals Inc

3.41 60.6 Mil
Healthcare

Cytokinetics Inc

3.27 58.2 Mil
Healthcare

Viking Therapeutics Inc

3.07 54.6 Mil
Healthcare

Gilead Sciences Inc

3.01 53.6 Mil
Healthcare

Vaxcyte Inc Ordinary Shares

2.49 44.2 Mil
Healthcare

argenx SE ADR

2.24 39.9 Mil
Healthcare